The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, p...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23815
- Acceso en línea:
- https://doi.org/10.1080/03007995.2017.1354821
https://repository.urosario.edu.co/handle/10336/23815
- Palabra clave:
- Nonsteroid antiinflammatory agent
Opiate
Tramadol
Narcotic analgesic agent
Nonsteroid antiinflammatory agent
Tramadol
Cancer pain
Cardiovascular disease
Central america
Chronic pain
Constipation
Disease severity
Drug abuse
Drug dependence
Drug efficacy
Drug indication
Drug safety
Drug tolerability
Fibromyalgia
Gastrointestinal symptom
Health care quality
Human
Musculoskeletal pain
Nausea
Nephrotoxicity
Pain
Postoperative pain
Posttraumatic pain
Randomized controlled trial (topic)
Respiration depression
Review
Side effect
South america
Vomiting
Aged
Analgesia
South and central america
Aged
Cancer pain
Chronic pain
Humans
Latin america
Pain management
Tramadol
Abuse
Latin america
Pain management
Prescription control
Tramadol
non-steroidal
opioid
Analgesics
Anti-inflammatory agents
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_bfbe54fcaac15b7fb93ac5fe6b1b8ea7 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23815 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
dc.title.spa.fl_str_mv |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
title |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
spellingShingle |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel Nonsteroid antiinflammatory agent Opiate Tramadol Narcotic analgesic agent Nonsteroid antiinflammatory agent Tramadol Cancer pain Cardiovascular disease Central america Chronic pain Constipation Disease severity Drug abuse Drug dependence Drug efficacy Drug indication Drug safety Drug tolerability Fibromyalgia Gastrointestinal symptom Health care quality Human Musculoskeletal pain Nausea Nephrotoxicity Pain Postoperative pain Posttraumatic pain Randomized controlled trial (topic) Respiration depression Review Side effect South america Vomiting Aged Analgesia South and central america Aged Cancer pain Chronic pain Humans Latin america Pain management Tramadol Abuse Latin america Pain management Prescription control Tramadol non-steroidal opioid Analgesics Anti-inflammatory agents |
title_short |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
title_full |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
title_fullStr |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
title_full_unstemmed |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
title_sort |
The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel |
dc.subject.keyword.spa.fl_str_mv |
Nonsteroid antiinflammatory agent Opiate Tramadol Narcotic analgesic agent Nonsteroid antiinflammatory agent Tramadol Cancer pain Cardiovascular disease Central america Chronic pain Constipation Disease severity Drug abuse Drug dependence Drug efficacy Drug indication Drug safety Drug tolerability Fibromyalgia Gastrointestinal symptom Health care quality Human Musculoskeletal pain Nausea Nephrotoxicity Pain Postoperative pain Posttraumatic pain Randomized controlled trial (topic) Respiration depression Review Side effect South america Vomiting Aged Analgesia South and central america Aged Cancer pain Chronic pain Humans Latin america Pain management Tramadol Abuse Latin america Pain management Prescription control Tramadol |
topic |
Nonsteroid antiinflammatory agent Opiate Tramadol Narcotic analgesic agent Nonsteroid antiinflammatory agent Tramadol Cancer pain Cardiovascular disease Central america Chronic pain Constipation Disease severity Drug abuse Drug dependence Drug efficacy Drug indication Drug safety Drug tolerability Fibromyalgia Gastrointestinal symptom Health care quality Human Musculoskeletal pain Nausea Nephrotoxicity Pain Postoperative pain Posttraumatic pain Randomized controlled trial (topic) Respiration depression Review Side effect South america Vomiting Aged Analgesia South and central america Aged Cancer pain Chronic pain Humans Latin america Pain management Tramadol Abuse Latin america Pain management Prescription control Tramadol non-steroidal opioid Analgesics Anti-inflammatory agents |
dc.subject.keyword.eng.fl_str_mv |
non-steroidal opioid Analgesics Anti-inflammatory agents |
description |
Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. Methods: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. Results: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol’s high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics–mainly controlled drugs (classical opioids)–is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. Conclusions: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients. © 2017 Informa UK Limited, trading as Taylor and Francis Group. |
publishDate |
2017 |
dc.date.created.spa.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:05:40Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:05:40Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1080/03007995.2017.1354821 |
dc.identifier.issn.none.fl_str_mv |
3007995 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23815 |
url |
https://doi.org/10.1080/03007995.2017.1354821 https://repository.urosario.edu.co/handle/10336/23815 |
identifier_str_mv |
3007995 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
1621 |
dc.relation.citationIssue.none.fl_str_mv |
No. 9 |
dc.relation.citationStartPage.none.fl_str_mv |
1615 |
dc.relation.citationTitle.none.fl_str_mv |
Current Medical Research and Opinion |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 33 |
dc.relation.ispartof.spa.fl_str_mv |
Current Medical Research and Opinion, ISSN:3007995, Vol.33, No.9 (2017); pp. 1615-1621 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027699710&doi=10.1080%2f03007995.2017.1354821&partnerID=40&md5=6d93f117df15722fb10b85cc88e5fa56 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Taylor and Francis Ltd |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167648109330432 |
spelling |
b327f855-0083-4db5-b9cf-1a849496e27b-149c35e73-e415-46ef-af65-8d0e2a16dc73-1f4498f80-b3b6-4614-90ff-bd3bb9910207-1bb5f482f-cfbc-47d5-a6a6-bee244a0bda2-16d8e2c70-71e3-497f-b3f5-a50500d3a5ec-19a2e77bd-ac48-4472-8ee9-2e485379bb48-1076c0a18-dc60-463a-b429-32109206fc6c-1707abfde-ca64-45e7-8c76-a7b31beb9cef-1ec793379-46be-489c-ab83-cdcb16d668ee-1844f616a-bb06-4abb-ae8b-44a368a57e6d-15351dfd4-4bc6-4016-89e6-377cc976ab0a-1f0e13369-062b-4f9f-8adf-88ad4cd2479a-18ff0c7f7-f530-4f0e-894e-f8af975c0f39-138f62a84-ca58-4aff-84d4-b9e82fbc9903-13cb6e085-ed62-4b53-95db-1e819a9e5f97-12020-05-26T00:05:40Z2020-05-26T00:05:40Z2017Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. Methods: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. Results: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol’s high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics–mainly controlled drugs (classical opioids)–is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. Conclusions: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients. © 2017 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/03007995.2017.13548213007995https://repository.urosario.edu.co/handle/10336/23815engTaylor and Francis Ltd1621No. 91615Current Medical Research and OpinionVol. 33Current Medical Research and Opinion, ISSN:3007995, Vol.33, No.9 (2017); pp. 1615-1621https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027699710&doi=10.1080%2f03007995.2017.1354821&partnerID=40&md5=6d93f117df15722fb10b85cc88e5fa56Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURNonsteroid antiinflammatory agentOpiateTramadolNarcotic analgesic agentNonsteroid antiinflammatory agentTramadolCancer painCardiovascular diseaseCentral americaChronic painConstipationDisease severityDrug abuseDrug dependenceDrug efficacyDrug indicationDrug safetyDrug tolerabilityFibromyalgiaGastrointestinal symptomHealth care qualityHumanMusculoskeletal painNauseaNephrotoxicityPainPostoperative painPosttraumatic painRandomized controlled trial (topic)Respiration depressionReviewSide effectSouth americaVomitingAgedAnalgesiaSouth and central americaAgedCancer painChronic painHumansLatin americaPain managementTramadolAbuseLatin americaPain managementPrescription controlTramadolnon-steroidalopioidAnalgesicsAnti-inflammatory agentsThe role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory PanelarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Santos Garcia J.B.Lech O.Campos Kraychete D.Rico M.A.Hernández-Castro J.J.Colimon F.Guerrero C.Sempértegui Gallegos M.Lara-Solares A.Flores Cantisani J.A.Amescua-Garcia C.Guillén Núñez M.D.R.Berenguel Cook M.D.R.Jreige Iskandar A.Bonilla Sierra P.10336/23815oai:repository.urosario.edu.co:10336/238152022-05-02 07:37:14.682426https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |